Polymorphisms in C-Reactive Protein and Glypican-5 Are Associated with Lung Cancer Risk and Gartrokine-1 Influences Cisplatin-Based Chemotherapy Response in a Chinese Han Population
Table 4
Relationship between rs2808630 of CRP and lung cancer risk (adjusted by gender and age).
Model
Genotype
Control (, %)
Case (, %)
OR (95% CI)
value
value adj.
AIC
BIC
Codominant
T/T
189 (65.4%)
218 (75.4%)
1.00
0.100
0.500
710.2
732.0
T/C
90 (31.1%)
64 (22.1%)
0.64 (0.43–0.97)
C/C
10 (3.5%)
7 (2.4%)
0.80 (0.28–2.30)
Dominant
T/T
189 (65.4%)
218 (75.4%)
1.00
0.036
0.180
708.3
725.8
T/C-C/C
100 (34.6%)
71 (24.6%)
0.66 (0.44–0.98)
Recessive
T/T-T/C
279 (96.5%)
282 (97.6%)
1.00
0.850
1
712.7
730.1
C/C
10 (3.5%)
7 (2.4%)
0.90 (0.32–2.58)
Overdominant
T/T-C/C
199 (68.9%)
225 (77.8%)
1.00
0.037
0.185
708.3
725.8
T/C
90 (31.1%)
64 (22.1%)
0.65 (0.43–0.98)
Log-additive
0.72 (0.51–1.02)
0.061
0.305
709.2
726.6
AIC: Akaike's information criterion; BIC: Bayesian information criterion. value was adjusted by Bonferroni correction.